Insider Shareholders with Direct Ownership of Cytek Biosciences, Inc. (CTKB)
This section provides a comprehensive overview of the insiders with direct ownership of Cytek Biosciences, Inc. (CTKB). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Cytek Biosciences, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Ming Yan
CHIEF TECHNOLOGY OFFICER |
193,125 | 2,280,791 | 6,042,126 $20.2 Million | 61 |
May 19, 2025
Reduced 0.02%
|
|
Wenbin Jiang
PRESIDENT AND CEO |
381,341 | 3,033,981 | 5,261,735 $17.6 Million | 57 |
May 19, 2025
Reduced 0.09%
|
|
Patrik Jeanmonod
CHIEF FINANCIAL OFFICER |
72,324 | 65,927 | 97,465 $325,533 | 37 |
Mar 11, 2024
Reduced 1.92%
|
|
Valerie Barnett
CHIEF LEGAL OFFICER |
114,527 | 38,871 | 83,673 $279,467 | 32 |
May 19, 2025
Reduced 3.26%
|
|
Allen Poirson
SVP BUS. AND CORP. DEV. |
32,149 | 11,946 | 59,981 $200,336 | 25 |
Nov 18, 2024
Reduced 1.21%
|
|
William D. Mc Combe
Chief Financial Officer |
68,983 | 13,237 | 55,746 $186,191 | 3 |
Jun 02, 2025
Added 38.57%
|
| 58,705 | 16,000 | 42,705 $142,634 | 5 |
Jun 05, 2025
Added 26.89%
|
|
|
Philippe Busque
SVP, GLOBAL SALES AND SERVICES |
30,996 | 12,079 | 18,917 $63,182 | 12 |
May 19, 2025
Reduced 4.74%
|
|
Paul Christopher Williams
CHIEF OPERATING OFFICER |
26,991 | 10,518 | 16,473 $55,019 | 14 |
Aug 19, 2024
Reduced 17.29%
|
| 15,706 | 0 | 15,706 $52,458 | 1 |
Jun 05, 2025
Added 50.0%
|
|
| 15,706 | 0 | 15,706 $52,458 | 1 |
Jun 05, 2025
Added 50.0%
|
|
| 15,706 | 0 | 15,706 $52,458 | 1 |
Jun 05, 2025
Added 50.0%
|
|
|
Jonathan Todd Garland
Chief Commercial Officer |
14,356 | 5,593 | 8,763 $29,268 | 4 |
Aug 18, 2023
Reduced 10.94%
|
| 7,997 | 0 | 7,997 $26,709 | 4 |
May 19, 2025
Added 15.38%
|
|
|
Gisele Dion
Director |
5,000 | 0 | 5,000 $16,700 | 1 |
Jul 22, 2021
Added 50.0%
|